Avita Medical, Inc. (ASX:AVH) has lodged its quarterly report on Form 10-Q with the United States Securities and Exchange Commission for the quarterly period ended September 30, 2026, disclosing 31,420,219 shares of common stock outstanding as of November 2, 2026.

Key Points

  • Avita Medical filed its Form 10-Q quarterly report for the period ended September 30, 2026 with the SEC.
  • The company reported 31,420,219 shares of common stock, par value $0.0001, outstanding as of November 2, 2026.
  • The company is incorporated in Delaware with an IRS Employer Identification Number of 85-1021707 and is headquartered in Valencia, California.
  • Avita Medical is listed on the Nasdaq Stock Market under the trading symbol RCEL, as well as on the ASX under the ticker AVH.
  • The company is classified as a smaller reporting company and is not classified as a large accelerated filer, accelerated filer, or emerging growth company.

Form 10-Q Filing Details for the September 2026 Quarter

Avita Medical, Inc. filed its quarterly report on Form 10-Q pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended September 30, 2026. The filing carries Commission File Number 001-39059. The company confirmed it has filed all reports required during the preceding 12 months and has submitted electronically every Interactive Data File required under Rule 405 of Regulation S-T. The company also confirmed it is not a shell company as defined under Rule 12b-2 of the Exchange Act.

Company Structure and Principal Office Location

Avita Medical, Inc. is incorporated in the state of Delaware, with an IRS Employer Identification Number of 85-1021707. The company's principal executive offices are located at 28159 Avenue Stanford, Suite 220, Valencia, CA 91355. Its common stock, with a par value of $0.0001 per share, is registered on the Nasdaq Stock Market LLC under the trading symbol RCEL. The company also lodges its filings with the Australian Securities Exchange, where it trades under the ticker AVH.

Risk Factors and Forward-Looking Statements

The Form 10-Q includes a note regarding forward-looking statements, with the company stating there have been no material changes to the Risk Factors as described in the Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on February 12, 2026 and lodged with the ASX on February 13, 2026. The quarterly report covers consolidated balance sheets as of September 30, 2026, and December 31, 2025, along with consolidated statements of operations, comprehensive loss, stockholders' equity, and cash flows for the three-month and nine-month periods ended September 30, 2026 and 2025.